CNE100004Q23
CNE100004Q23
SINO BIOLOGICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 17.9B EUR | 7.85B EUR | 8.63B EUR |
Enterprise Value | 14.81B EUR | 7.64B EUR | 8.28B EUR |
Valuation Multiples | |||
Trailing P/E | 108.98x | 46.8x | 62.79x |
Forward P/E | 67.8x | -- | -- |
Price to Sales | 23.3x | 10.47x | 12.39x |
Price to Book | 3.42x | 1.5x | 1.62x |
EV/Revenue | 19.28x | 10.19x | 11.9x |
EV/EBITDA | 80.87x | 39.4x | 49.51x |
Price to FCF (P/FCF) | 461.13x | 203.42x | 194.81x |
EV/FCF | 381.57x | 197.95x | 187.09x |
FCF Yield | 0.22% | 0.49% | 0.51% |